Showing 3341-3360 of 8875 for: Cochrane Systematic Reviews Back
- Honey and lozenges for children with non‐specific cough
Cochrane Systematic Reviews, 15-Apr-2009
Chronic non-specific cough is a chronic, dry cough of in the absence of identifiable respiratory disease or known aetiology. Although it is usually not reflective of an underlying severe illness, it does cause significant morbidity, and as such relief fr
- Honey as a topical treatment for wounds
Cochrane Systematic Reviews, 6-Mar-2015
Honey is a viscous, supersaturated sugar solution derived from nectar gathered and modified by the honeybee, Apis mellifera. Honey has been used since ancient times as a remedy in wound care. Evidence from animal studies and some trials has suggested that
- Honey for acute cough in children
Cochrane Systematic Reviews, 10-Apr-2018
Cough causes concern for parents and is a major cause of outpatient visits. Cough can impact quality of life, cause anxiety, and affect sleep in children and their parents. Honey has been used to alleviate cough symptoms. This is an update of reviews prev
- Hormonal and intrauterine methods for contraception for women aged 25 years and younger
Cochrane Systematic Reviews, 10-Aug-2015
Women between the ages of 15 and 24 years have high rates of unintended pregnancy; over half of women in this age group want to avoid pregnancy. However, women under age 25 years have higher typical contraceptive failure rates within the first 12 months o
- Hormonal contraception for women exposed to HIV infection
Cochrane Systematic Reviews, 6-May-2014
Concern about a possible association of hormonal contraception with HIV acquisition has been raised by three types of evidence. Firstly, high-dose progestogen treatment greatly increases HIV acquisition in female non-human primates. Secondly, biological p
- Hormonal contraceptives for contraception in overweight or obese women
Cochrane Systematic Reviews, 11-Aug-2016
Obesity has reached epidemic proportions around the world. Effectiveness of hormonal contraceptives may be related to metabolic changes in obesity or to greater body mass or body fat. Hormonal contraceptives include oral contraceptives (OCs), injectables,
- Hormonal therapy in advanced or recurrent endometrial cancer
Cochrane Systematic Reviews, 1-Apr-2015
Endometrial cancer is a cancer of the lining of the womb and worldwide is the seventh most common cancer in women. Treatment with hormones is thought to be beneficial in patients with endometrial cancer.
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
Cochrane Systematic Reviews, 28-Mar-2013
Adequate contraceptive advice is important in both women with diabetes mellitus type 1 and type 2 to reduce the risk of maternal and infant morbidity and mortality in unplanned pregnancies. A wide variety of contraceptives are available for these women. H
- Hormone replacement for osteoporosis in women with primary biliary cirrhosis
Cochrane Systematic Reviews, 12-Nov-2011
Women with primary biliary cirrhosis often suffer from postmenopausal osteoporosis due to their age, or osteoporosis secondary to their liver disease, or treatments provided for their liver disease. Hormone replacement increases bone mineral density and r
- Hormone replacement therapy after surgery for epithelial ovarian cancer
Cochrane Systematic Reviews, 28-Jan-2020
Women who have undergone surgical treatment for epithelial ovarian cancer (EOC) may develop menopausal symptoms due to immediate loss of ovarian function following surgery and chemotherapy. Women may experience vasomotor symptoms, sleep disturbance, diffi
- Hormone replacement therapy for cognitive function in postmenopausal women
Cochrane Systematic Reviews, 23-Jan-2008
As estrogens have been found in animal models to be associated with the maintenance and protection of brain structures, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by medication could be protective agains
- Hormone replacement therapy for women previously treated for endometrial cancer
Cochrane Systematic Reviews, 15-May-2018
Endometrial cancer is the sixth most common cancer in women worldwide and most commonly occurs after the menopause (75%) (globocan.iarc.fr). About 319,000 new cases were diagnosed worldwide in 2012. Endometrial cancer is commonly considered as a potential
- Hormone replacement therapy for women with type 1 diabetes mellitus
Cochrane Systematic Reviews, 6-May-2013
There is conflicting information about the impact of the menopause on glycaemic control amongst women with type 1 diabetes. Some menopausal women with type 1 diabetes are treated with hormone replacement therapy (HRT) but the effects of this treatment hav
- Hormone replacement therapy to maintain cognitive function in women with dementia
Cochrane Systematic Reviews, 21-Jan-2009
As estrogens have been shown to have several potentially beneficial effects on the central nervous system, it is biologically plausible that maintaining high levels of estrogens in postmenopausal women by means of estrogen replacement therapy (ERT) could
- Hormone therapy for endometriosis and surgical menopause
Cochrane Systematic Reviews, 21-Jan-2009
Endometriosis is characterized by the presence of ectopic endometrial tissue that might lead to many distressing and debilitating symptoms. Despite available studies supporting standard hormone therapy for women with endometriosis and post-surgical menopa
- Hormone therapy for preventing cardiovascular disease in post‐menopausal women
Cochrane Systematic Reviews, 10-Mar-2015
Evidence from systematic reviews of observational studies suggests that hormone therapy may have beneficial effects in reducing the incidence of cardiovascular disease events in post-menopausal women, however the results of randomised controlled trials (R
- Hormone therapy for sexual function in perimenopausal and postmenopausal women
Cochrane Systematic Reviews, 31-May-2013
The perimenopausal and postmenopausal periods are associated with many symptoms, including sexual complaints.
- Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
Cochrane Systematic Reviews, 6-Oct-2022
Premature ovarian insufficiency (POI) is a clinical syndrome resulting from loss of ovarian function before the age of 40. It is a state of hypergonadotropic hypogonadism, characterised by amenorrhoea or oligomenorrhoea, with low ovarian sex hormones (oes
- Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
Cochrane Systematic Reviews, 15-Aug-2012
Reduced circulating estrogen levels around the time of the menopause can induce unacceptable symptoms that affect the health and well-being of women. Hormone therapy (both unopposed estrogen and estrogen/progestogen combinations) is an effective treatment
- Hormones for suspected impaired fetal growth
Cochrane Systematic Reviews, 20-Jan-2003
It has been suggested that oestrogens may improve fetal growth due to an increase in nutritional supply to the fetus from greater uterine blood flow.
